Dermatomyositis: An Update on Diagnosis and Treatment
- PMID: 32096127
- DOI: 10.1007/s40257-020-00502-6
Dermatomyositis: An Update on Diagnosis and Treatment
Abstract
Dermatomyositis is a rare inflammatory disease with characteristic cutaneous findings and varying amounts of systemic involvement. Patients may present with skin disease alone, have concomitant muscle disease, or have extracutaneous manifestations such as pulmonary disease or an associated malignancy. Given such diverse presentations, dermatomyositis is both a diagnostic and therapeutic challenge. However, a prompt diagnosis is of utmost importance to institute adequate therapy and screen patients for an associated malignancy. Dermatologists should play a crucial role in the diagnosis and management of patients with dermatomyositis as cutaneous disease tends to be chronic, negatively impact quality of life, and be more recalcitrant to therapy. In this review, we discuss diagnosis, with a focus on myositis-specific antibodies and their associated phenotypes. We also review therapies available for this often refractory skin disease.
Similar articles
-
Dermatomyositis: Diagnosis and treatment.J Am Acad Dermatol. 2020 Feb;82(2):283-296. doi: 10.1016/j.jaad.2019.05.105. Epub 2019 Jul 4. J Am Acad Dermatol. 2020. PMID: 31279813 Review.
-
A case of dermatomyositis with the anti-signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy.J Dermatol. 2019 Jul;46(7):e251-e253. doi: 10.1111/1346-8138.14790. Epub 2019 Jan 28. J Dermatol. 2019. PMID: 30690762 No abstract available.
-
Dermatomyositis: Clinical features and pathogenesis.J Am Acad Dermatol. 2020 Feb;82(2):267-281. doi: 10.1016/j.jaad.2019.06.1309. Epub 2019 Jul 4. J Am Acad Dermatol. 2020. PMID: 31279808 Review.
-
Management of cutaneous dermatomyositis: current therapeutic options.Am J Clin Dermatol. 2006;7(6):341-51. doi: 10.2165/00128071-200607060-00002. Am J Clin Dermatol. 2006. PMID: 17173468 Review.
-
Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.Folia Med (Plovdiv). 2017 Mar 1;59(1):7-13. doi: 10.1515/folmed-2017-0003. Folia Med (Plovdiv). 2017. PMID: 28384112 Review.
Cited by
-
Identification and validation of interferon-stimulated gene 15 as a biomarker for dermatomyositis by integrated bioinformatics analysis and machine learning.Front Immunol. 2024 Nov 4;15:1429817. doi: 10.3389/fimmu.2024.1429817. eCollection 2024. Front Immunol. 2024. PMID: 39559355 Free PMC article.
-
Identification of shared immune infiltration characteristic molecules in dermatomyositis and nasopharyngeal carcinoma using bioinformatics: Traits in dermatomyositis and nasopharyngeal cancer.Skin Res Technol. 2024 Aug;30(8):e13871. doi: 10.1111/srt.13871. Skin Res Technol. 2024. PMID: 39081134 Free PMC article.
-
Development of the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA): A De Novo IGA of Cutaneous Manifestations of Dermatomyositis.Dermatol Ther (Heidelb). 2024 Aug;14(8):2127-2138. doi: 10.1007/s13555-024-01220-1. Epub 2024 Jul 8. Dermatol Ther (Heidelb). 2024. PMID: 38976170 Free PMC article.
-
TIF1-γ Positive Dermatomyositis with Spontaneous Muscular Hematoma in the Context of Ovarian Cancer: A Novel Survival Case Report.J Inflamm Res. 2024 Jun 18;17:3915-3920. doi: 10.2147/JIR.S469401. eCollection 2024. J Inflamm Res. 2024. PMID: 38911988 Free PMC article.
-
Imaging spectrum of atraumatic muscle disorders: a radiologist's guide.Skeletal Radiol. 2024 Aug;53(8):1449-1464. doi: 10.1007/s00256-024-04659-7. Epub 2024 Mar 23. Skeletal Radiol. 2024. PMID: 38520541 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
